Sierra Oncology (NASDAQ: SRRA)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Sierra Oncology (NASDAQ: SRRA) through any online brokerage.
The latest price target for Sierra Oncology (NASDAQ: SRRA) was reported by Jefferies on Thursday, April 14, 2022. The analyst firm set a price target for 55.00 expecting SRRA to rise to within 12 months (a possible 0.58% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Sierra Oncology (NASDAQ: SRRA) is $54.685 last updated Today at May 20, 2022, 2:45 PM UTC.
There are no upcoming dividends for Sierra Oncology.
Sierra Oncology’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for Sierra Oncology.
Sierra Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.